Protagenic Therapeutics, Inc. (NASDAQ:PTIX) Q4 2023 Earnings Call Transcript
Operator: Greetings. Welcome to the Protagenic Therapeutics' Fourth Quarter and Fiscal Year 2023 Earnings Call. At this time, all participants are in a listen-only mode.
Performance Technologies Inc (PTIX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | AQR Capital Management Cliff Asness | 0 | $0 | -100% | 0% |
| 2. | Touradji Capital Management Paul Touradji | 0 | $0 | -100% | 0% |
| 3. | Renaissance Technologies Jim Simons | 0 | $0 | -100% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.61 | 6,000 | Director | 25,000 | 2010-06-01 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.60 | 215,100 | Large Shareholder | 947,415 | 2013-11-19 | Filing | |
| $3.20 | 31,600 | Large Shareholder | 1,162,515 | 2013-11-08 | Filing | |
| $2.78 | 100,000 | Large Shareholder | 1,194,115 | 2013-10-01 | Filing | |
| $1.25 | 100,000 | Large Shareholder | 1,294,115 | 2013-06-28 | Filing | |
| $2.00 | 100,000 | Large Shareholder | 1,394,115 | 2012-02-22 | Filing |
News See All
10 Best Biotech Penny Stocks to Buy Now
The scintillating pace of technological advancement in the world over the past few decades has transformed the fortunes of the human race, freeing up important time for some of the top scientific minds...
Billionaire Hedge Funds
